Clinical Trial Update: A Multicenter Study: Dexmedetomidine Combined With Sufentanil for Patient Controlled Intravenous Analgesia After Caesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial evaluating dexmedetomidine combined with sufentanil for patient-controlled intravenous analgesia after cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Caesarean Section Postoperative Pain
• Postoperative Pain

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Sufentanil (sufentanil)

Snippet

Sponsor: Obstetrics & Gynecology Hospital of Fudan University | Conditions: Postoperative Pain | Phase 4 | Status: COMPLETED